Media Mentions
Tara Raghavan Quoted in Wall Street Journal Article on the FDA’s ‘Project Optimus’ Initiative
September 5, 2024
Benesch Intellectual Property Partner Tara Raghavan was featured in The Wall Street Journal’s article, “FDA Wants Safer Cancer Drugs, But Some Startups Fear Unintended Consequences.” Tara discussed the impact of the FDA’s Project Optimus initiative, noting that it could extend the drug development process by six to twelve months, potentially increasing costs and challenges for smaller companies.
The article highlights the FDA’s efforts through Project Optimus to encourage drugmakers to re-evaluate cancer drug dosing to balance safety and efficacy better, aiming to reduce unnecessary side effects from high doses. However, some startups worry that the initiative could raise development time and costs, putting them at a disadvantage compared to larger competitors.
To read the full article, click here.
Latest News
Kris Chandler and Jonathan R. Todd Featured in Crain’s Executive Insights on AI in Transportation & Logistics
Benesch Partners Jonathan R. Todd and Kris Chandler are featured in the latest Crain’s Executive Insights roundtable, “How Logistics Companies …
Benesch Partners Mark Keaney and David Hudson Featured in San Francisco Business Times on Powered Land and Data Center Development
Mark Keaney, a partner in Benesch’s Litigation Practice Group, and David Hudson, a partner in Benesch’s Real Estate Practice Group, …
Benesch Partner Kevin Frankel Featured on Bloomberg Law Podcast Discussing the Changing State Attorneys General Landscape
Kevin Frankel, a partner at Benesch and lead of the firm’s State Attorneys General Practice, was featured on the Bloomberg …
Benesch Partner Kevin Frankel Quoted in The Wall Street Journal on Potential Terrorist Designations for Nonprofits
The Wall Street Journal recently quoted Kevin Frankel, a partner at Benesch and lead of the firm’s State Attorneys General …